ACE 2023
ACE 2022
Kristen Jones
Erica Wassack
Lisa Ashworth
Sue Duran
Jeff Robins
Suzanne Keyes
Deborah Pearce
Confirmed session topics listed (exact titles to be determined).
1:00 p.m. Golf Outing on Ocean Course
2:00 p.m. to 5:00 p.m.

Wednesday, February 23, 2022
2:00 pm – 5:00 pm
Rio Mar Salon 3&4

FREE for ACA | ACVP Members & PPHI Supporters; $79 for non-members

Pre-Conference Business Workshop: Building the Pharmacy of Tomorrow… Today

“Working” workshop explores new ways to serve patients and protect your financial future

What if you could afford to add new services that would create new revenue, increase patient retention, attract new patients, double (or more) per patient lifetime value, all while bringing greater prosperity to your pharmacy, your community, and your family?

Attend this Pharmacy of Tomorrow workshop to learn how this exciting, new initiative is helping independent pharmacy owners across the country fight back and win the war for hometown and community prosperity.

Join Ben Coakley, co-owner of Waypoint Rx and co-creator of the Pharmacy of Tomorrow to learn:

  • A simple, new business model that can generate hundreds of thousands of dollars per year;
  • The easiest and quickest way to add new services your patients will love, and;
  • An entirely new way to look a wealth that will add more joy, meaning and purpose to your business, your relationships (in and out of the pharmacy), and your life!

Don’t miss this opportunity to build the Pharmacy of Tomorrow today.

This is a “working” workshop!

Attendees are asked to bring two pieces of information: a recent P & L statement and a breakdown of your patients by payer type. You will not be asked to share this information. Ben will show you how to estimate the new income you can earn next year (and beyond) and the impact it can have on your bottom line.

Ben promises, “We’re going to illustrate how just one Pharmacy of Tomorrow initiative can have an immediate positive impact on the health of your financial ratios.”

Add this session to your conference registration now, and take the first step towards creating your own Pharmacy of Tomorrow.

Benjamin Coakley, CFP™, ChFC, CLTC    

Ben has been an advisor to business owners since 2004 and specializes in empowering independent community pharmacy owners to rekindle their love and passion for pharmacy. He holds himself accountable for helping the people he serves accomplish their most important life and financial goals. He is the co-creator of the Pharmacy of Tomorrow initiative, The Purpose of Capital financial success system, the Pharmacy Insurance Group, and the Families Saving Families community vitality protection program.

Ben is a lifelong resident of Summerville, SC and is passionate about giving back to his community. He was president of the Summerville Jaycees in 2006/07 and is a founding member of The Summerville Evening Rotary Club. He holds a Bachelor’s Degree in Marketing from Clemson University, and is a graduate of Leadership Dorchester.
2:30 p.m. to 7:30 p.m. Registration Open
5:30 p.m. to 7:30 p.m. Welcome Reception
7:30 a.m. to 8:30 a.m. Exhibitor Experience with Breakfast
8:30 a.m. to 9:30 a.m. Opening Session — State of the College
9:30 a.m. to 10:30 a.m.

A Physician’s Road to Recovery
UAN: 0201-9999-22-001-L05-P/T
Adam Hill, MD
Division, Chief of Pediatric Palliative Care, IU Health
This session is sponsored by Pharmacists Public Health Initiatives.

Activity Description: Share my story of addiction recovery to normalize seeking help while working in the medical profession. To distinguish mental health and addiction. Discuss the barriers and obstacles in the way. How can we all advocate for change.

Learning Objectives for Pharmacists and Pharmacy Technicians:
1. Identify contributing factors to address in the medical workforce
2. Describe obstacles / barriers preventing mental health treatment
3. Discuss self-care strategies and institutional advocacy
4. Discover effects of stigma, stereotyping medical conditions
10:30 a.m. to 11:00 a.m. Break
This break is sponsored by Pharmacist Mutual Insurance Company.            
11:00 a.m. to 12:00 p.m.

Burnout, Patient Safety, and the Road to Resiliency
UAN: 0201-9999-22-002-L05-P/T
Kristen Jones, PharmD
Pharmacy Risk Management Consultant, Pharmacists Mutual Insurance Company
This session is sponsored by Pharmacists Mutual Insurance Company.

Activity Description: Healthcare provider burnout is an epidemic that is receiving deserved attention. Burnout has powerful negative effects both on providers but also on patients and healthcare systems. Learn how burnout presents in today’s pharmacy professional and implications on patient safety. Come away with methods to mitigate burnout and head down the road to resilience.

Intended audience: Pharmacist, pharmacy technicians, and other healthcare providers

Learning Objectives for Pharmacists and Pharmacy Technicians:
1. Identify signs and symptoms of professional burnout
2. Explain the impact of burnout on professional practice and patient safety
3. Describe methods to mitigate burnout and improve well-being
4. Select individual practices to foster resiliency and self-care
12:00 p.m. to 1:30 p.m. Fellowship Luncheon and Installation of Officers
Sponsored by Prescribe Wellness, A TRHC Solution.
1:30 p.m. to 2:30 p.m.

Rise of the Resistance: The Force of Antimicrobial Stewardship
UAN: 0201-9999-22-003-L01-P/T
Erica Wassack, PharmD, DICVP, FACVP, FSVHP
Senior Clinical Pharmacist
Mississippi State University College of Veterinary Medicine

Activity Description: Antimicrobial agents are essential for human and animal health and welfare. Most antimicrobials used to treat infections in humans are also used in animals. The increase in resistance strains prevent prescribers from selecting effective antibiotic therapy and threaten One Health. Antimicrobial stewardship programs provide strategies to preserve the effectiveness and availability of antimicrobial drugs. Attendees will gain new perspectives on antimicrobial stewardship and clinical pearls for implementation of antibiotic stewardship programs in their practice.

Learning Objectives:
1. Review cause of antimicrobial resistance
2. Identify antimicrobial stewardship principles
3. Describe one health collaboration for stewardship
2:30 p.m. to 2:45 p.m. Break
2:45 p.m. to 3:45 p.m.

Collaborative relationships: A key ingredient to successful pharmacy practice
UAN: 0201-9999-22-004-L04-P/T
Deborah Pestka, PharmD, PhD
Research Scientist, University of Minnesota

This session is sponsored by Doctor Multimedia.

Activity Description: This presentation will describe various collaborations pharmacists can make and the impact this can have on pharmacy practice. Examples from previous studies on the impact of collaboration will be shared. Forming these collaborations will be key to the advancement of pharmacy practice.

Learning Objectives for Pharmacists & Pharmacy Technicians:
1. Describe the need for collaborative relationships
2. Describe the benefits of collaborative relationships to practice and patients
3. Identify potential collaborative partners in your practice setting
4. Identify strategies for creating collaborative relationships
8:00 a.m. to 9:00 a.m. Exhibitor Experience with Breakfast

Compounding Pharmacy Track

9:00 a.m. to 10:30 a.m.

Neurology and Opportunities for Compounding
UAN: 0201-9999-22-005-L07-P/T
Paul Lofholm, PharmD, FACA
Lofholm Consulting, Consultant Pharmacist

Activity Description: This presentation will identify the role of the neurologist and how pharmacists assist the neurologist in meeting unmet therapeutic needs for the patient through compounding. And for the pharmacy technician, this presentation will offer compounding ideas to meet the needs of the neurologist.

The intended audience is pharmacists and pharmacy technicians.

Learning Objectives for Pharmacists:
1. Identify the role of the neurologist in treating disease, his review of systems, and the establishment of therapeutic goals.
2. Provide the neurologist with therapeutic options which are not available commercially to better meet the needs of the patient.
3. Identify specific disease states to be covered including Parkinson’s Disease, low dose naltrexone, and pain.
4. Select a therapeutic preparation for the treatment of pain and present it to the group with the rationale for use.

Learning Objectives for Pharmacy Technicians:
1. Identify at least 6 drugs that are compounded and indicated for the treatment of pain.
2. Explain how the Certificate of Assay is used to compound Naltrexone taking into account the water content when compounding.
3. Explore how to compound low-dose levodopa for Parkinson’s patients
4. Define local anesthetic agents for topical use using the eutectic technique to prepare a quality preparation
10:30 a.m.. to 11:00 a.m. Break
This break is sponsored by TICKERWORKS.
11:00 a.m. to 12:00 p.m.

Compounding for Pediatric Patients
UAN: 0201-9999-22-006-L07-P/T
Lisa D. Ashworth, BS Pharm, RPh, BCSCP, FACA
System Compounding Specialist and Clinical Pharmacist,  Children’s Health System of Texas
This session is sponsored by Xenex Labs, Inc.

Activity Description: This session will explain some challenges in choosing an API, excipient, vehicle, and flavorings for a compounded formulation. Vehicles and excipients can affect a patient clinically – balancing their potential adverse effects is important. Stability and storage needs, especially for chronic medications has to be considered. This presentation will lead to better patient care by understanding how the components in a compounded formulation can affect a patient clinically.

The intended audience is compounding pharmacists and technicians who may compound for pediatric patients.

Learning Objectives for Pharmacists & Pharmacy Technicians:
1. Explain some challenges in choosing an API, excipient, vehicle, and flavorings for a compounded formulation.
2. Discuss some adverse effects that can occur from vehicles, excipients, and flavorings that have the potential to affect a patient clinically.
3. Describe the differences in potency and texture that may occur in using a commercial product or a raw material as the API.
12:00 p.m. to 1:00 p.m. Lunch
1:00 p.m. to 2:00 p.m.

Ensuring Patient Access to Quality Personalized Medications: Our Experience in Spain
UAN: 0201-9999-22-007-L04-P/T
Diego Marro, PharmD, PhD

Activity Description: In order to correctly understand what is happening close to home, it is sometimes interesting to broaden our gaze and look at what is happening further away. In this session we will reflect on the similarities and differences between the situation of compounding in the USA and in Europe, studying the case of Spain. In a very different healthcare and pharmaceutical organization context, but where the needs of patients are basically the same.

We will also discover the programs and actions that the Spanish Society of Individualized Medication (LASEMI) has been developing with the aim of promoting, facilitating access and improving the quality of compounding in practice.

Learning Objectives:
1. Describe factors affecting patient access to personalized medications.
2. Identify differences between ensuring quality in drug manufacturing and compounding of personalized medications.
3. Compare the situation of pharmaceutical compounding in the US to other countries.

Veterinary Pharmacy Track

9:00 a.m. to 10:30 a.m.

Equine Pharmacology
UAN: 0201-9999-22-008-L08-P/T
Sue Hudson Duran, RPh,MS,PhD, DICVP, FSVHP,FACVP
GMP Pharmacist/Professor Emeritus, Auburn University/Auburn Equine SPP

Activity Description: Veterinarians would practice equine medicine depend on pharmacists that are training in proper preparation, compounding and dispensing medication. The pharmacists need to be aware of medications in horses that may be toxic. The practicing pharmacists needs to know the difficulties of dosing horses in order to prepare safe and efficacious medication. Drug interactions ae also a skill that pharmacists may contribute for the veterinarian as many horses may be on polypharmacy . Safe handling of equine medications will be discusses as well as an occupational safety step to protect your employees.

At the completion of this activity, the participant will be able to:
1. Review the anatomy and physiology of the horse
2. Discuss absorption differences in the equine
3. Review therapy of common equine diseases
4. Identify improved knowledge of therapy and limits of absorption in a horse
5. Define safe handling of equine medications to prevent side effects
10:30 a.m.. to 11:00 a.m. Break
This break is sponsored by TICKERWORKS.
11:00 a.m. to 12:00 p.m.

PK/PD Considerations in Developing Anesthetic Plans for Critically Ill Patients using Partial Intravenous Anesthesia (PIVA) and Total Intravenous Anesthesia (TIVA)
UAN: 0201- 9999-22-009-L01-P/T
Tereza Stastny, MD, DVM, DACVECC
Veterinary Critical Care Specialist, Arizona Veterinary Emergency and Critical Care

Activity Description: Understanding PK/PD considerations of available anesthetic agents are necessary in order to optimize critically ill patients’ (ASA status of 3 +) anesthetic plans. Partial intravenous anesthesia technique (PIVA) is used to lower the inspired concentration of an inhalational anesthetic by concurrent use of injectable drugs. This technique reduces the incidence of undesirable side effects and provides superior quality of anesthesia and analgesia. Total Intravenous Anesthesia (TIVA) is used to eliminate the need for inhalational anesthetic altogether and further reduces risk of undesirable side-effects. Additionally, close monitoring by well-trained staff, preoperative optimization of the patient’s condition, and a chronological plan for intraoperative management, anticipation of complications, and a plan for postoperative care should all be included when preparing to anesthetize a critically ill patient.

This presentation will focus on the PK/PD considerations of available veterinary drugs and implementing PIVA and TIVA in various clinical scenarios.

Learning Objectives:
1. Understand PK/PD considerations of anesthetic agents relevant to critically ill patients
a. Define minimum alveolar concentration (MAC)
i. Identify MAC sparing agents and conditions
b. Explain Blood Gas Partition Coefficient (BGPC)
i. Identify inhalants induction rate based on their BGPCs
2. Define partial intravenous anesthesia technique (PIVA)
a. Understand PK considerations of CRIs
b. Identify common drugs used for PIVA
c. Understand how to calculate PIVA CRI doses
3. Define total intravenous anesthesia technique (TIVA)
a. Identify common drugs used for TIVA
4. Practice creating anesthetic protocols for critically ill cases
12:00 p.m. to 1:00 p.m. Lunch
1:00 p.m. to 2:00 p.m.

You Need to Treat What? Meeting the Unique Pharmacy Needs of Zoo Animals
UAN: 0201-9999-22-010-L07-P/T
Ryan Colburn, DVM, Veterinarian
John Ball ZooThomas A. Magnifico, RPh, FACA, FACVP,
Pharmacist/Veterinary Specialist, Keystone PharmacyActivity Description: The goal of this presentation is to share the unique partnership that often exists between zoo veterinarians and pharmacists as we work together to find creative ways to treat a whole array of different species. A variety of cases will be presented to illustrate the wide array of challenges that zoological species can present to their care team and the many ways that pharmacists can identify unique solutions to assist veterinarians in meeting those challenges. This presentation will seek to give both pharmacists and pharmacy technicians a greater appreciation of strategies that can be used to meet the needs of some of the world’s most unique patients.Learning Objectives:
• Discuss the challenges the many zoological species present to their care team
• Identify ways zoo veterinarians and pharmacists can work together for the benefit of zoo patients
• Describe some unique cases that are present in zoo medicine

Functional Medicine Track

9:00 a.m. to 10:30 a.m.

Vitamins Fact or Fiction: Functionally Using Nutrients to Impact Positive Patient Outcomes
UAN: 0201-9999-22-011-L01-P/T
Jeff Robins RPh, FAARFM, FACA, ABAAHP
Summit Functional Consulting
Consultant/Functional Pharmacist

Activity Description: Many of our patients eat the standard American diet (SAD). Along with poor daily diet, most of our patients are taking medications that cause drug induced nutritional deficiencies. Our patients are at risk for further health degradation due to their nutritional status. Jeff will help you understand how to pick nutritional products that are efficacious in your patients. You will learn how to meet your patient’s nutritional needs generally, and for specific common ailments and disease states. Not only does this type of practice offer a sustainable profit model, your practice will set itself apart from the competition by giving in depth nutritional care to your patients.

Learning Objectives:
1. Identify if the produced vegetables and fruits in the United States are less nutritious now than in 1950
2. Recall the main nutrients Americans are at risk of being deficient in
3. Write down the dosages for the top five nutrients each pharmacist thinks would be most beneficial to their patients
4. Compile a strategy to talk to your patients
10:30 a.m.. to 11:00 a.m. Break
This break is sponsored by TICKERWORKS.
11:00 a.m. to 12:00 p.m.

The Role of Dysbiosis in Women’s Health
UAN: 0201-9999-22-012-L01-P/T
Suzanne Keyes, PHARMD, FACA, IFMCP
Keyes Pharmacy & 180 Wellness, Owner PIC

Activity Description: An estimated 28 million women have known energy and metabolism problems due to hypothyroidism. 1.3 million women entering menopause annually. Approximately 2/3rds of the population are currently dealing with symptoms of adrenal exhaustion.

Attend this session on Women’s Health and you will:
1) leave with the ability to distinguish the overlapping symptoms of these 3 conditions
2) be familiar with the biological pathways and drug-induced nutrient depletions occurring from common prescriptions
3) be comfortable recommending nutritional supplements to support the pathways, foods to avoid and food plans to recommend as well as multiple lifestyle modifications that support the triad of conditions

At the conclusion of this session, participants will:
1) Describe the individual biological pathways of estrogen metabolism and optimal thyroid function
2) Define the overlapping symptoms associated with estrogen dominance and hypothyroidism and the interplay between the two
3) Review and recall the drug induced nutrient depletions of common medications that would affect patients with these conditions
4) Identify an individualized plan for patients that include: nutrition, nutraceutical support and lifestyle modifications
12:00 p.m. to 1:00 p.m. Lunch
1:00 p.m. to 2:00 p.m.

Implementing Personalized Nutrition into Pharmacy Practice
UAN: 0201-9999-22-013-L04-P/T
Lara Zakaria
PharmD, MS, CNS, CDN, IFMCP

Activity Description: Nutrition intervention is considered first-line in the treatment of most chronic diseases. However, most pharmacists don’t have extensive training in nutrition or don’t feel confident making nutritional recommendations in the practice. In this workshop-style session, we will learn simple, turn-key assessment solutions that will turn any pharmacist into the community expert allowing you to integrate foundational nutrition support for your patients.

Learning Objectives:
Upon completion of this activity, participants will:
1. Define the role of nutritional intervention in cardiometabolic disease state management
2. Identify key opportunities for assessment of nutrition status
3. Apply case-based learning, towards implementing and monitoring nutritional interventions in a variety of disease states

Break

5:30 p.m. to 8:30 p.m. Rum Tasting Fundraiser for ACA Foundation (additional ticketed event)
5:30 p.m. to 6:30 p.m. Reception / Cocktail Hour
6:30 p.m. to 10:00 p.m. Fiesta Puerto Rico
8:00 a.m. to 9:00 a.m. Exhibitor Experience with Breakfast
9:00 a.m.. to 10:00 a.m.

Medical Cannabis Patient Cases & Why Healthcare Professionals Need to be Involved
UAN: 0201-9999-22-014-L01-P/T
Leah Johnson PharmD, RPh
Medical Cannabis & Clinical Integrative Health Consultant Pharmacist
Alchemist Consulting

Activity Description: This will educate Pharmacist and healthcare professionals on how to identify potential interactions between cannabis, and prescription or supplemental therapy. This will also help identify what is a good starting dose of cannabis for each individual patient. The presentation will also review dose alteration methods.

Learning Objectives:
At the conclusion of this program, the participating pharmacist or technician will be able to:
1. Identify potential prescription, supplement, cannabis, or herbal side effects which could be affecting the patient.
2. Discuss how to choose a good starting dose of cannabis for each individual patient.
3. Identify different dose alteration methods.
10:00 a.m. to 10:15 a.m. Break
10:15 a.m. to 11:45 a.m.

Legal Update
UAN: 0201-9999-22-015-L03-P/T
Deborah A. Pearce, Attorney-At-Law
Deborah A. Pearce, LLC

Activity Description: Compounding pharmacists and practitioners must remain aware of ongoing legal and regulatory developments so that they may tailor their practices accordingly and avoid disciplinary actions and/or disruptions to business. This presentation will review recent agency guidance’s and interpretations and stakeholder responses for both human and veterinary compounding practices.

Learning Objectives:
1. Discuss the issues surrounding compounding drugs for animals using bulk drug substances
2. Define the specific problems, and court directives, with regard to the FDA’s MOU
3. Identify the “findings” and stakeholder positions regarding compounded BHRT
11:45 a.m. Conference Adjourns

Wednesday, February 23

8:00 a.m. to 12:00 p.m. ACA Board of Directors
12:00 p.m.  to 1:00 p.m. Joint Board of Directors Luncheon
1:00 p.m. to 3:00 p.m. ACVP Board of Directors

Thursday, February 24

4:00 p.m. to 5:30 p.m. ACA Research & Education Foundation (REF) Board of Directors